Personal information

Oncology, Endocrinology, Celular and Molecular Biology

Biography

My name is Ricardo Miguel dos Santos Rodrigues, graduated member number 3859 of the Biologists' Order, and SPEDM number 1048. I completed my Bachelor’s degree in Biology, in the field of Molecular Biology and Genetics, in 2019, in the Faculty of Sciences of Lisbon (FCUL), where I also obtained a Master’s degree in Molecular Biology and Genetics in 2022. Currently I am a PhD student in the doctoral program in Health Sciences of NOVA Medical School | Faculdade de Ciências Médicas da Universidade NOVA de Lisboa. I developed a Master’s dissertation entitled, "Study of molecular and cellular mechanisms involved in anaplastic thyroid carcinoma aggressiveness and response to therapy", which was supervised by Dr. Branca Cavaco, Principal Investigator of the Molecular Endocrinology Group, and co-supervised by Dr. Tiago Nunes da Silva, Endocrinologist and Researcher, held at Unidade de Investigação em Patobiologia Molecular (UIPM), at Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG). Aggressive thyroid cancer, specially anaplastic thyroid cancer (ATC) is the rarest form of thyroid cancer, but it is also the most aggressive and fatal form. My Master´s project aimed to understand the molecular and cellular mechanisms involved in ATC aggressiveness, and response/resistance to therapy, since these mechanisms are still poorly clarified. Throughout the project, I acquired a considerable theoretical knowledge, and laboratorial skills in molecular and cellular Biology, and particularly in the Oncobiology field. I am developing specific aspects of the above mentioned research, in the same group and I am currently PhD student in Health Sciences in NOVA medical School, entitled "Targeted therapy in aggressive thyroid cancer - unravelling novel resistance mechanisms, predictive biomarkers and therapeutic targets" Besides this scientific passion for cancer research, I have played soccer since I was eight years old, which allowed me to improve companionship, team effort, team trust, and commitment, which, in my opinion, are also important characteristics in a researcher.

Activities

Employment (1)

Instituto Português de Oncologia Francisco Gentil: Lisbon, Lisbon, PT

2020-09-21 to present (Unidade de Investigação em Patobiologia Molecular)
Employment
Source: Self-asserted source
Ricardo Rodrigues

Education and qualifications (3)

Faculdade de Ciências Médicas da Universidade NOVA de Lisboa: Lisbon, Lisbon, PT

2022-09-12 to present | Doctoral program in Health Sciences
Education
Source: Self-asserted source
Ricardo Rodrigues

Faculdade de Ciências da Universidade de Lisboa: Lisbon, Lisbon, PT

2019-09-17 to 2022-02-22 | Masters degree in Molecular Biology and Genetics (Departamento de Biologia Vegetal)
Education
Source: Self-asserted source
Ricardo Rodrigues

Faculdade de Ciências da Universidade de Lisboa: Lisbon, Lisbon, PT

2016-09-01 to 2019-07-22 | Biology - Molecular Biology and Genetics (Departamento de Biologia Vegetal)
Education
Source: Self-asserted source
Ricardo Rodrigues

Professional activities (9)

Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo: Lisbon, Lisbon, PT

2022 to present (Number 1048)
Membership
Source: Self-asserted source
Ricardo Rodrigues

Ordem dos Biólogos: Lisbon, PT

2019 to present (Number 3859 )
Membership
Source: Self-asserted source
Ricardo Rodrigues

Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo: Lisbon, PT

2023 | Honerable mention in Basic Investigation
Distinction
Source: Self-asserted source
Ricardo Rodrigues

Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo: Lisbon, PT

2023 | Bolsa "Projecto de Investigação SPEDM"
Distinction
Source: Self-asserted source
Ricardo Rodrigues

Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo: Lisbon, PT

2023 | Bolsa "Edward Limbert MERCK/SPEDM"
Distinction
Source: Self-asserted source
Ricardo Rodrigues

Fundação para a Ciência e Tecnologia: Lisbon, PT

2022-09-12 | PhD scholarship - UI/BD/154256/2022
Distinction
Source: Self-asserted source
Ricardo Rodrigues

Faculdade de Ciências da Universidade de Lisboa: Lisbon, PT

2019-09 to 2022-02-22 | Course president for the role of Course committee student representative from the Master's in Molecular Biology and Genetics (Departamento de Biologia Vegetal)
Invited position
Source: Self-asserted source
Ricardo Rodrigues

Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo: Lisbon, PT

2021 | Honerable mention in Causistic
Distinction
Source: Self-asserted source
Ricardo Rodrigues

Faculdade de Ciências da Universidade de Lisboa: Lisbon, PT

2019 to 2020 | Tutoria de Biologia (Departamento de Biologia Vegetal)
Invited position
Source: Self-asserted source
Ricardo Rodrigues

Funding (3)

Estudo da Combinação terapêutica de lenvatinib e inibidores do EGFR em cancro da tiróide bem diferenciado agressivo

2023 to present | Grant
Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo (Lisbon, PT)
Source: Self-asserted source
Ricardo Rodrigues

Targeted therapy in aggressive thyroid cancer - Evaluation of the usefulness of ctDNA analysis in liquid biopsies and identification of candidate molecular biomarkers

2023 to present | Grant
Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo (Lisbon, PT)
Source: Self-asserted source
Ricardo Rodrigues

PhD scholarship

2022 to present | Contract
Fundação para a Ciência e Tecnologia (Lisbon, PT)
Source: Self-asserted source
Ricardo Rodrigues

Works (32)

DEVELOPMENT OF A RET/PTC1 THYROID CANCER CELL VARIANT WITH LENVATINIB RESISTANCE – A TOOL TO INVESTIGATE DRUG RESPONSE AND NOVEL THERAPEUTIC APPROACHES

Congresso Português de Endocrinologia - 76ª Reunião Anual da SPEDM
2025-02-02 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-4519610

Contributors: Rodrigues, Ricardo; Ana Saramago; Pires, Carolina; Carmo Martins; Ana Sofia Carvalho; Hans C. Beck; Rune Matthiesen; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

DEVELOPMENT OF A RET/PTC1 THYROID CANCER CELL VARIANT WITH LENVATINIB RESISTANCE – A TOOL TO INVESTIGATE DRUG RESPONSE AND NOVEL THERAPEUTIC APPROACHES

Congresso Português de Endocrinologia - 76ª Reunião Anual da SPEDM
2025-02-02 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-4519604

Contributors: Rodrigues, Ricardo; Ana Saramago; Pires, Carolina; Carmo Martins; Ana Sofia Carvalho; Hans C. Beck; Rune Matthiesen; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

LENVATINIB AND EGFR COMBINED INHIBITION DIFFERENTIALLY MODULATES TARGETS AND PATHWAYS IN RET/PTC, NRAS AND BRAF MUTATED THYROID CANCER CELLS

Congresso Português de Endocrinologia - 76ª Reunião Anual da SPEDM
2025-02-02 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-4519598

Contributors: Rodrigues, Ricardo; Pires, Carolina; Carmo Martins; Valeriano Leite; Tiago Nunes da Silva; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

LENVATINIB AND EGFR COMBINED INHIBITION DIFFERENTIALLY MODULATES TARGETS AND PATHWAYS IN RET/PTC, NRAS AND BRAF MUTATED THYROID CANCER CELLS

Congresso Português de Endocrinologia - 76ª Reunião Anual da SPEDM
2025-02-02 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-4519593

Contributors: Rodrigues, Ricardo; Carolina Pires; Carmo Martins; Valeriano Leite; Tiago Nunes da Silva; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

Lenvatinib in the treatment of anaplastic thyroid cancer: experience of a single center.

Congresso Português de Endocrinologia - 76ª Reunião Anual da SPEDM
2025-02-02 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-4519564

Contributors: Catarina Regala; Carlos Marques; Ana Saramago; Rodrigues, Ricardo; Branca Cavaco; Valeriano Leite; Tiago Nunes da Silva
Source: check_circle
CIÊNCIAVITAE

Liquid biopsy in the follow-up of a patient with BRAF positive anaplastic thyroid cancer and breast cancer

46th Annual Meeting of the European Thyroid Association (ETA) 2024
2024-09-07 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-4348476

Contributors: Tiago Nunes da Silva; Rodrigues, Ricardo; Ana Saramago; Pires, Carolina; Miguel Rito; Saudade Andre; Raquel Dias; Valeriano Leite; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

Liquid biopsy in the follow-up of a patient with BRAF positive anaplastic thyroid cancer and breast cancer

46th Annual Meeting of the European Thyroid Association (ETA) 2024
2024-09-07 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-4348478

Contributors: Tiago Nunes da Silva; Rodrigues, Ricardo; Ana Saramago; Pires, Carolina; Miguel Rito; Saudade André; Raquel Dias; Valeriano Leite; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

Island hitchhikers: pathogen agents of Madeira and Azores ticks

Ticks and Tick-borne Diseases
2024-07-24 | Journal article
SOURCE-WORK-ID:

cv-prod-id-3528089

Contributors: Fernanda Rosa; Carla Silva; Rodrigues, Ricardo; Mariana Esteves-Vieira; Sara Rosa; Deodália Dias,; Francisco Pina-Martins
Source: check_circle
CIÊNCIAVITAE

Establishment and characterisation of a RET/PTC1 thyroid cancer-derived cell line (TPC-1) variant with resistance to lenvatinib.

6th ASPIC International Congress
2024-04-29 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-4274526

Contributors: Rodrigues, Ricardo; Ana Saramago; Pires, Carolina; Carmo Martins; Tiago Silva; Leite, Valeriano; Branca M. Cavaco
Source: check_circle
CIÊNCIAVITAE

Establishment and characterisation of a RET/PTC1 thyroid cancer-derived cell line (TPC-1) variant with resistance to lenvatinib.

6th ASPIC International Congress
2024-04-29 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-4274525

Contributors: Rodrigues, Ricardo; Ana Saramago; Pires, Carolina; Carmo Martins; Tiago Silva; Leite, Valeriano; Branca M. Cavaco
Source: check_circle
CIÊNCIAVITAE

IS LIQUID BIOPSY A PROMISING TOOL FOR BRAF+ ANAPLASTIC THYROID CANCER MANAGEMENT? A CASE REPORT

Congresso Português de Endocrinologia – 75ª Reunião Anual da SPEDM
2024-02-04 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3667019

Contributors: Rodrigues, Ricardo; Tiago Nunes da Silva; Ana Saramago; Pires, Carolina; Miguel Rito; Saudade André; Raquel Dias; Valeriano Leite; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

TARGETING EGFR IN COMBINATION WITH LENVATINIB IN THYROID CANCER CELLS

75ª Reunião Anual da SPEDM
2024-02-04 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3666791

Contributors: Rodrigues, Ricardo; Pires, Carolina; Carmo Martins; Valeriano Leite; Tiago Nunes da Silva; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes

Endocrine
2023-12-17 | Journal article
SOURCE-WORK-ID:

cv-prod-id-2835568

Contributors: Joana Simões-Pereira; Ana Saramago; Ricardo Rodrigues; Marta Pojo; Pires, Carolina; Mariana Horta; Dolores López-Presa; et al. Autor correspondente: Joana Simões-Pereira.
Source: check_circle
CIÊNCIAVITAE

SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anaplastic Thyroid Cancer Cells

NMS Research Week
2023-10-16 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-3527584

Contributors: Rodrigues, Ricardo; Ana Teresa Pinto; Marta Pojo; Matthiesen, Rune; Ana Sofia Carvalho; Hans C. Beck; Pires, Carolina; et al.
Source: check_circle
CIÊNCIAVITAE

SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anaplastic Thyroid Cancer Cells.

NMS Research Week
2023-10-16 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3527567

Contributors: Rodrigues, Ricardo; Ana Teresa Pinto; Marta Pojo; Diana Pacheco Sousa; Rune Matthiesen; Ana Sofia Carvalho; Hans C. Beck; et al.
Source: check_circle
CIÊNCIAVITAE

Effectiveness of lenvatinib in progressive metastatic radioiodine refractory well differentiated and poorly differentiated thyroid carcinoma

45th Annual Meeting of the European Thyroid Association (ETA) 2023
2023-09-01 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3496033

Contributors: Tiago Nunes da Silva; Catarina Regala; Rodrigues, Ricardo; João Roque; Inês Damásio; Branca M. Cavaco; Valeriano Leite; Corresponding author: Tiago Nunes da Silva.
Source: check_circle
CIÊNCIAVITAE

SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anaplastic Thyroid Cancer Cells

Cancers
2023-09-01 | Journal article
Contributors: Ana Teresa Pinto; Marta Pojo; Ricardo Rodrigues; Diana Pacheco Sousa; Rune Matthiesen; Ana Sofia Carvalho; Hans C. Beck; Carolina Pires; Rodrigo Eduardo; Joana Simões Pereira et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin

European Thyroid Journal
2023-03-28 | Journal article
SOURCE-WORK-ID:

cv-prod-id-4181596

Contributors: Dias, Daniela; Damásio, Inês; Marques, Pedro; Simões, Helder; Rodrigues, Ricardo; Cavaco, Branca Maria; Leite, Valeriano
Source: check_circle
CIÊNCIAVITAE

Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma

European Thyroid Journal
2023-02-28 | Journal article
Contributors: João Roque; Tiago Nunes Silva; Catarina Regala; Ricardo Rodrigues; Valeriano Leite
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

24 HORAS PARA REESCREVER O DESFECHO DE UM CARCINOMA ANAPLÁSICO COM DABRAFENIB E TRAMETINIB

74ª Reunião Anual da Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo
2023-02-02 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3286717

Contributors: Catarina Regala; Tiago Nunes da Silva; Ricardo Rodrigues; Branca M. Cavaco; Valeriano Leite; Corresponding author: Catarina Regala.
Source: check_circle
CIÊNCIAVITAE

SPRY4 COMO POTENCIAL MEDIADOR DO PAPEL ANTI-TUMORAL DOS MACRÓFAGOS NO CARCINOMA ANAPLÁSICO DA TIRÓIDE

2023-02-02 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3286711

SOURCE-WORK-ID:

cv-prod-id-3745373

Contributors: Ricardo Rodrigues; Ana Pinto; Marta Pojo; Diana Pacheco Sousa; Ana Sofia Carvalho; Hans C. Beck; Matthiesen, Rune; et al. Corresponding author: Ana Pinto.
Source: check_circle
CIÊNCIAVITAE

Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study

European Journal of Endocrinology
2023-01-10 | Journal article
Contributors: Tiago Nunes da Silva; Ricardo Rodrigues; Ana Saramago; Carolina Pires; Miguel Rito; Mariana Horta; Carmo Martins; Valeriano Leite; Branca M Cavaco
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A clinical and molecular study of a real-world cohort of BRAF V600E anaplastic thyroid carcinoma treated with Dabrafenib and Trametinib

44th Annual Meeting of the European Thyroid Association
2022-09-10 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3138555

Contributors: Tiago Nunes da Silva; Ricardo Rodrigues; Miguel Rito; Ana Saramago; Pires, Carolina; Mariana Horta; Valeriano Leite; Branca M. Cavaco
Source: check_circle
CIÊNCIAVITAE

The dual role of tumour-associated macrophages in anaplastic thyroid cancer

5th ASPIC International Congress.
2022-06-30 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-3144881

Contributors: Rodrigues, Ricardo; Ana Pinto; Marta Pojo; Diana Pacheco Sousa; Ana Sofia Carvalho; Hans C. Beck; Rune Matthiesen; et al. Corresponding author: Ana Pinto.
Source: check_circle
CIÊNCIAVITAE

The dual role of tumour-associated macrophages in anaplastic thyroid cancer

5th ASPIC International Congress
2022-06-30 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3138556

Contributors: Ricardo Rodrigues; Ana Pinto; Marta Pojo; Diana Pacheco Sousa; Ana Sofia Carvalho; Hans C. Beck; Rune Matthiesen; et al. Corresponding author: Marta Pojo.
Source: check_circle
CIÊNCIAVITAE

Study of molecular and cellular mechanisms involved in anaplastic thyroid carcinoma aggressiveness and response to therapy

Fundação da Faculdade de Ciências da Universidade de Lisboa
2022-02-22 | Dissertation or Thesis
SOURCE-WORK-ID:

cv-prod-id-2932568

Source: check_circle
CIÊNCIAVITAE

Estudo molecular de doentes com carcinoma anaplásico da tiróide tratados com Dabrafenib e Trametinib

73ª reunião anual da Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo
2022-02-05 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-2835196

Contributors: Tiago Nunes da Silva; Ricardo Rodrigues; Miguel Rito; Ana Saramago; Pires, Carolina; Mariana Horta; Valeriano Leite; Branca M. Cavaco; Corresponding author: Tiago Nunes da Silva.
Source: check_circle
CIÊNCIAVITAE

Factores preditivos da resposta/avidez ao iodo nos carcinomas papilares da tiróide metastáticos

73ª reunião anual da Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo
2022-02-04 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3098858

Contributors: Joana Simões-Pereira; Ana Saramago; Ricardo Rodrigues; Marta Pojo; Pires, Carolina; Mariana Horta; Dolores López-Presa; et al. Corresponding author: Joana Simões-Pereira.
Source: check_circle
CIÊNCIAVITAE

Factores preditivos da resposta/avidez ao iodo nos carcinomas papilares da tiróide metastáticos.

73ª reunião anual da Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo
2022-02-04 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-2835231

Contributors: Joana Simões Pereira; Ana Saramago; Ricardo Rodrigues; Pires, Carolina; Marta Pojo; Mariana Horta; Dolores López-Presa; et al. Corresponding author: Joana Simões Pereira.
Source: check_circle
CIÊNCIAVITAE

Molecular characterization of patients with BRAF V600E-positive anaplastic thyroid cancer under Dabrafenib and Trametinib treatment

II ASPIC-ASEICA INTERNATIONAL MEETING - CURRENT TRENDS IN PRECISION MEDICINE IN CANCER
2021-10-14 | Conference poster
SOURCE-WORK-ID:

cv-prod-id-2835212

Contributors: Ricardo Rodrigues; Miguel Rito; Mariana Horta; Ana Saramago; Pires, Carolina; Valeriano Leite; Tiago Nunes da Silva; Branca M. Cavaco; Corresponding author: Ricardo Rodrigues.
Source: check_circle
CIÊNCIAVITAE

Molecular characterization of patients with BRAF V600E-positive anaplastic thyroid cancer under Dabrafenib and Trametinib treatment

II ASPIC-ASEICA INTERNATIONAL MEETING - CURRENT TRENDS IN PRECISION MEDICINE IN CANCER
2021-10-14 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-3138561

Contributors: Ricardo Rodrigues; Miguel Rito; Mariana Horta; Ana Saramago; Pires, Carolina; Valeriano Leite; Tiago Nunes da Silva; Branca Maria Cavaco
Source: check_circle
CIÊNCIAVITAE

Mudança de paradigma no tratamento do carcinoma anaplásico da tiroide com dabrafenib e trametinib: resultados de um estudo caso-controlo

72ª reunião anual da Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo
2021-01-23 | Conference abstract
SOURCE-WORK-ID:

cv-prod-id-2835179

Contributors: Tiago Nunes da Silva; Mariana Horta; Miguel Rito; Ricardo Rodrigues; Branca M. Cavaco; Valeriano Leite; Autor correspondente: Tiago Nunes da Silva.
Source: check_circle
CIÊNCIAVITAE